5D Capital Corp

TheraPsil is a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy to treat end-of-life distress.

TheraPsil was formed in 2019 and is made up of healthcare professionals, patients, community members, and advocates.  After over 100 days of avocating TheraPsil facilitated precedent-setting and tangible progress in the fight for compassionate access to psilocybin therapy when it helped 4 Canadians suffering from end-of-life distress, due to a terminal illness, access approved 'section 56 exemptions' from the Minister of Health, on August 4th 2020. This was the first time section 56 exemptions for psilocybin had been approved for patients since psilocybin was made a controlled substance in 1974, in Canada.